Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Los

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancerK T Robbins, A M Storniolo, C Kerber, et al.
British Journal of Cancer|September 1, 1995
Enhancement of drug sensitivity of human malignancies by epidermal growth factorR Kröning, J A Jones, D K Hom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1989
Two specific T cell factors that initiate immune responses in murine allograft systems. A comparison of biologic functionsR J Vandebriel, R A De Weger, G Los, et al.
Biochemical Pharmacology|July 5, 1991
Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic actionG Los, E Verdegaal, H P Noteborn, et al.
Cancer Research|March 1, 1992
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavityG Los, O A Smals, M J van Vugt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in ratsG Los, P Sminia, J Wondergem, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 20, 1998
Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergismR A Weisman, R Christen, G Los, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formationG Los, f A Blommaert, R Barton, et al.
British Journal of Cancer|February 22, 2014
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedulesJ Murray, H Thomas, P Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancerK T Robbins, A M Storniolo, C Kerber, et al.
British Journal of Cancer|September 1, 1995
Enhancement of drug sensitivity of human malignancies by epidermal growth factorR Kröning, J A Jones, D K Hom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1989
Two specific T cell factors that initiate immune responses in murine allograft systems. A comparison of biologic functionsR J Vandebriel, R A De Weger, G Los, et al.
Biochemical Pharmacology|July 5, 1991
Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic actionG Los, E Verdegaal, H P Noteborn, et al.
Cancer Research|March 1, 1992
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavityG Los, O A Smals, M J van Vugt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in ratsG Los, P Sminia, J Wondergem, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 20, 1998
Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergismR A Weisman, R Christen, G Los, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formationG Los, f A Blommaert, R Barton, et al.
British Journal of Cancer|February 22, 2014
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedulesJ Murray, H Thomas, P Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.
Pageof 7